Fibrates in CVD: a step towards personalised medicine.
Staels
Bart
B
Université Lille Nord de France, Lille, France. Bart.Staels@pasteur-lille.fr
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002995:Clofibric Acid / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D047493:PPAR alpha / Q000819:agonists
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D047493:PPAR alpha; D002995:Clofibric Acid